Tenderwize
Zurück zur Suche

Italy – Administrative healthcare services – PROCEDURA APERTA PER L’AFFIDAMENTO AD UNA CONTRACT RESEARCH ORGANIZATION (CRO) DEI SERVIZI PER LA GESTIONE DELLO STUDIO CLINICO MULTICENTRICO RANDOMIZZATO: “COMBOSEQ - SEQUENCE STRATEGY OF IMMUNEONCOLOGY (IO-IO) VS IO-TYROSINE KINASE INHIBITORS (TKI) FOLLOWED BY TKI IN METASTATIC RENAL CELL CARCINOMA (MRCC): A RANDOMIZED PHASE 3 STUDY MEETURO AND FICOG TRIAL”, MEDIANTE PIATTAFORMA SINTEL

FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI·MILANO, Italy·EUR 2M·Deadline Nov 24, 2026 · 18 days left·Open·Services
High value
0/100

Opportunity Score

High riskLow complexity
ServicesOpen
Warum diese Bewertung?

Chance

0 / 100

Komplexität

0 / 100

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Eckdaten der Ausschreibung

Öffentlicher Auftraggeber
FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI
Land
Italien
CPV
75122000 - Administrative healthcare services
Frist
Nov 24, 2026
Geschätzter Wert
EUR 2M

KI-Analyse der Ausschreibung

Tenderwize erstellt auf Basis der TED-Bekanntmachung und der Vergabeunterlagen eine KI-Analyse dieser Ausschreibung: Leistungsumfang, zentrale Anforderungen, Eignungskriterien, Risiken und Fragen an den Auftraggeber. Die Analyse wird beim Öffnen der Ausschreibung erstellt.

Auftraggeber

Ort

MILANO, ITA

Kennung

80018230153

Tätigkeit

Health

Lose (1)

LOT-0001

PROCEDURA APERTA PER L’AFFIDAMENTO AD UNA CONTRACT RESEARCH ORGANIZATION (CRO) DEI SERVIZI PER LA GESTIONE DELLO STUDIO CLINICO MULTICENTRICO RANDOMIZZATO: “COMBOSEQ - SEQUENCE STRATEGY OF IMMUNEONCOLOGY (IO-IO) VS IO-TYROSINE KINASE INHIBITORS (TKI) FOLLOWED BY TKI IN METASTATIC RENAL CELL CARCINOMA (MRCC): A RANDOMIZED PHASE 3 STUDY MEETURO AND FICOG TRIAL”, MEDIANTE PIATTAFORMA SINTEL

PROCEDURA APERTA PER L’AFFIDAMENTO AD UNA CONTRACT RESEARCH ORGANIZATION (CRO) DEI SERVIZI PER LA GESTIONE DELLO STUDIO CLINICO MULTICENTRICO RANDOMIZZATO: “COMBOSEQ - SEQUENCE STRATEGY OF IMMUNEONCOLOGY (IO-IO) VS IO-TYROSINE KINASE INHIBITORS (TKI) FOLLOWED BY TKI IN METASTATIC RENAL CELL CARCINOMA (MRCC): A RANDOMIZED PHASE 3 STUDY MEETURO AND FICOG TRIAL”, MEDIANTE PIATTAFORMA SINTEL PREVISTA CLAUSOLA DI ADESIONE EX-POST A FAVORE DEGLI ENTI DEL CONSORZIO COMPRESA LA FONDAZIONE DEL 300%, COME DA ART. 2 DEL DISCIPLINARE DI GARA

ServicesEU fundedElectronic submission

EUR 2M

Geschätzter Wert

Dauer

Nov 2026 - Nov 2026

Kategorie

Administrative healthcare services

Vergabedetails

Veröffentlichungsdatum
03 Nov 2026
Sprachen
Italian

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
766672-2026

Dokumente (1)

Ähnliche Ausschreibungen

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy